It is reported that mTOR controls NF-κB activity in cancer cells via the interaction with and stimulation of IKK, which is dependent on the mTOR-associated protein Raptor, while rapamycin dissociates Raptor from mTOR, thereby inhibiting IKK activation [35]. The gene discussed is MTOR; the disease is cancer.